Sepsis ImmunoScore vs Triomics
A sepsis score for adults in the ED or hospital and a trial-screening worklist for oncology coordinators are not rivals for one purchase.
Triomics suits a cancer center screening patients for trials. The vendor says PRISM screens upcoming patients against every active trial each night and gives coordinators a cited worklist. It lists Epic, OncoEMR, iKnowMed and Cerner. Memorial Sloan Kettering announced a deployment in November 2025 and discloses financial interests in the company.
Prenosis suits a hospital that treats suspected sepsis in the ED. Sepsis ImmunoScore scores adults from up to 22 EHR parameters into four risk bands, and the vendor says it has not been validated in the ICU or Labor and Delivery. The product page names no EHR vendor.
Prenosis holds FDA De Novo authorization DEN230036, granted April 2, 2024, under 21 CFR 880.6316. Triomics makes no FDA claim, and openFDA's 510(k) endpoint returns no match for its name.
Decision support · Reviewed November 2, 2026
Sepsis ImmunoScore
by Prenosis
AI sepsis risk score from up to 22 EHR parameters for adults with suspected sepsis in the ED or hospital, FDA De Novo authorized.
Triomics
by triomics inc.
Oncology AI agents that match patients to clinical trials, prepare visits and curate cancer registries from notes, reports and faxes.
When to pick each one
Sepsis ImmunoScore
- FDA De Novo DEN230036 for sepsis prediction
- Up to 22 EHR parameters, four risk bands
Triomics
- Epic, OncoEMR, iKnowMed and Cerner listed
- Vendor says nightly trial screening
- Vendor says approved on Epic App Marketplace
Score
Each row shows points earned of points available under the published rubric.
Sepsis ImmunoScore
37of 100
Triomics
12of 100
| Dimension | Sepsis ImmunoScore | Triomics | Difference |
|---|---|---|---|
| FDA clearance | 12 / 12 | 0 / 12 | +12 |
| HIPAA / SOC2 / BAA | 0 / 10 | 0 / 10 | 0 |
| EHR integrations (count) | 0 / 5.6 | 2.8 / 5.6 | -2.8 |
| Top-3 EHR coverage (Epic / Oracle / Athena) | 0 / 4.8 | 3.4 / 4.8 | -3.4 |
| Bidirectional write-back | 0 / 1.2 | 0 / 1.2 | 0 |
| Peer-reviewed papers | 14.7 / 21 | 0 / 21 | +14.7 |
| RCT / meta-analysis / systematic review | 0 / 9 | 0 / 9 | 0 |
| Funding & adoption signal | 3 / 12 | 3 / 12 | 0 |
| Pricing transparency | 1.3 / 2.5 | 1.3 / 2.5 | 0 |
| Years in market | 0 / 6 | 0 / 6 | 0 |
Scroll horizontally to see every column.
Pricing
Sepsis ImmunoScore
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. Demo or contact only. |
Triomics
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. Demo request and synthetic-data sandbox offered. |
Evidence
Sepsis ImmunoScore
FDA decisions
DEN230036 (opens in new tab)De Novo2024-04-02
Sepsis ImmunoScore
Peer-reviewed
2 PubMed records name Sepsis ImmunoScore.
Triomics
FDA decisions
No FDA decision cited in our research as of November 2, 2026.
Compliance and integrations
Documented from each vendor’s own pages.
| Spec | Sepsis ImmunoScore | Triomics |
|---|---|---|
| Free tier | ||
| HIPAA | ||
| SOC 2 Type II | ||
| EHR integrations | Not specified | Epic, OncoEMR, iKnowMed, Cerner |
| Founded | n/a | n/a |
| HQ | US | US |
Scroll horizontally to see both columns.
Common questions
Open the full decision support comparison
Differential diagnosis, treatment guidance, drug interactions, evidence-grounded Q&A. The CDS landscape ranges from the UpToDate gold standard to physician-only OpenEvidence. We compared what clinicians actually use.